FINWIRES · TerminalLIVE
FINWIRES

Tadawul Shares Start Week Flat as Corporate Earnings Roll In, OPEC+ Focus

By

The Tadawul All Share Index started the week subdued at 0.05% in the green on Sunday as investors focused on OPEC+'s next crude output policy after the United Arab Emirates' exit from the group.

The seven members of the OPEC+ agreed to raise crude production in June by 188,000 barrels per day, with the group continuing to monitor market conditions for market stability. Saudi Arabia, the de facto leader of the group, will be required to produce 10.3 million barrels per day for the month.

In other news, US President Donald Trump warned of the potential resumption of military strikes if Iran "misbehaves". On the Iranian side, Foreign Minister Seyed Abbas Araghchi said that it is open to diplomatic talks as long as the US switches its approach.

Back at home, Arabian Centres Co. (SASE:4321), d/b/a/ Cenomi Centers, and Umm Al Qura for Development and Construction (SASE:4325) posted lower results for the first quarter of 2026. Meanwhile, SAL Saudi Logistics Services (SASE:4263) logged a 2.297% and 16.072% increase in net profit and revenue, respectively.

"Net profit increased by 2.3% compared to the same quarter last year, reaching SAR 156.6 million versus SAR 153.1 million. This increase was mainly driven by the growth in revenue from the Cargo Ground Handling Division, along with the Company's continued focus on enhancing operational efficiency, improving business agility, and optimizing costs, reflecting the overall resilience of its performance," SAL Saudi Logistics Services said in its report.

SAL Saudi Logistics Services and Cenomi Centers ticked up at 0.30% and 1.99% at closing, while Umm Al Qura for Development closed 0.99% lower.

Looking ahead to the week, the economic calendar will see the release of Saudi Arabia's April edition of the Riyad Bank Purchasing Managers' Index on Tuesday, and the April unemployment figures of the US on Friday.

Related Articles

Asia Markets

US Equity Indexes Scale New Peaks This Week Amid Lift From Mega-Cap Earnings, Crude Oil

US equity indexes jumped this week as communications services and energy topped sector charts in a broad-based rally, reflecting the positive impact of mega-cap earnings and crude oil.* The S&P 500 closed at 7,230.12 on Friday versus 7,153.06 a week ago. The Nasdaq Composite stood at about 25,114.44, compared with 24,774.11 a week earlier. The Dow Jones Industrial Average ended at 49,499.27, versus 49,153.47 at the end of last week.* All but one sector, basic materials, rose this week. The top five sectors included financials, consumer defensive, and real estate, which shows a broadening of leadership to value-oriented areas.* Three Magnificent-7 stocks ended the week lower -- Meta Platforms (META), Nvidia (NVDA), and Microsoft (MSFT), according to data compiled by Finviz. Of the remaining four mega-caps, Alphabet (GOOG, GOOGL) led the pack with a gain of almost 12%. Except for Nvidia, all Mag-7 companies have so far reported quarterly results, with four of the six firms trading higher this week.* Among companies with a market capitalization of more than $200 billion, the top gainer was Intel (INTC), whose strong quarterly results translated into a weekly gain of almost 21%.* Brent crude oil futures soared to a four-year high this week before retreating, and West Texas Intermediate futures remained above the psychologically important $100 mark.* On Friday, Iran handed Washington a new proposal for ending the war, offering hints of compromise, The Wall Street Journal reported. The two sides remain far apart, however, on substantive issues of reopening the Strait of Hormuz and Iran's nuclear program, people familiar with the matter told the WSJ.* "They want to make a deal but I'm not satisfied with it," Trump told reporters at the White House Friday, according to Bloomberg. "We just had a conversation with Iran. Let's see what happens. But I would say that I am not happy."

Dow JonesNasdaq CompositeS&P 500$GOOG$GOOGL$INTC$META$MSFT$NVDA
Asia Markets

Exchange-Traded Funds Advance as US Equities Rise After Midday Friday

Broad Market IndicatorsBroad-market exchange-traded fund IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) edged up 1%.US equity indexes rose after midday Friday, with technology and consumer discretionary helping push the S&P 500 and Nasdaq Composite to record highs, while crude oil futures slumped.EnergyIShares US Energy ETF (IYE) and the State Street Energy Select Sector SPDR (XLE) each shed about 1.5%.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) was up 1.4%; iShares US Technology ETF (IYW) rose 1.3%, and iShares Expanded Tech Sector ETF (IGM) gained 1.3%.The State Street SPDR S&P Semiconductor (XSD) climbed 1%, and iShares Semiconductor (SOXX) was up 0.5%.FinancialThe State Street Financial Select Sector SPDR (XLF) added 0.1%. Direxion Daily Financial Bull 3X Shares (FAS) rose 0.2%, and its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), lost 0.3%.CommoditiesCrude oil fell 2.6%, and the United States Oil Fund (USO) slipped 3.1%. Natural gas rose fractionally, and the United States Natural Gas Fund (UNG) added 0.3%.Gold on Comex added 0.4%, and the State Street SPDR Gold Shares (GLD) gained 0.5%. Silver rose 3%, and iShares Silver Trust (SLV) was up 3.1%.ConsumerThe State Street Consumer Staples Select Sector SPDR (XLP) fell 0.3%. The Vanguard Consumer Staples ETF (VDC) and iShares Dow Jones US Consumer Goods (IYK) also declined.The State Street Consumer Discretionary Select Sector SPDR (XLY) gained 0.6%. VanEck Retail ETF (RTH) dipped 0.1%, and the State Street SPDR S&P Retail (XRT) was down 0.7%.Health CareThe State Street Health Care Select Sector SPDR (XLV) fell 0.3%, iShares US Healthcare (IYH) shed 0.2%, and Vanguard Health Care ETF (VHT) was 0.2% lower. IShares Biotechnology ETF (IBB) dipped 1%.IndustrialThe State Street Industrial Select Sector SPDR (XLI) fell 0.7%. Vanguard Industrials Index Fund (VIS) and iShares US Industrials (IYJ) were also lower.CryptocurrencyIn midday activity, bitcoin (BTC-USD) added 2.4%. Among cryptocurrency ETFs, ProShares Bitcoin ETF (BITO) rose 2.7%, ProShares Ether ETF (EETH) gained 2.2%, and ProShares Bitcoin & Ether Market Cap Weight ETF (BETH) was 2.4% higher.

Dow Jones^EEM^EXI^FAS^FAZ^GLD^IBB^IGM^IGV^IPK^IVV^IWMNasdaq Composite^IYE^IYH^IYJ^IYK^IYW^PMR^QQQ^RTH^SOXXS&P 500^SPY^UNG^USO^VDC^VHT^VIS^XLE^XLF^XLI^XLK^XLP^XLV^XRT^XSD$BETH$BITO$EETH
Asia Markets

European Markets Quiet on May Day, FTSE Edges Lower; UK Manufacturing Reaches Near 4-Year High

Major European stock markets were closed for May Day Friday, except for the FTSE 100, which was edging 0.1% lower.In the UK, the seasonally adjusted S&P Global UK Manufacturing Purchasing Managers' Index rose to 53.7 in April, which is its highest reading since May 2022.Meanwhile, the average house price in the UK rose 3% on an annual basis in April to 278,880 British pounds, according to the Nationwide House Price Index.In corporate news, Aon reported Q1 adjusted earnings Friday of $6.48 per diluted share, up from $5.67 a year earlier. Analysts polled by FactSet expected $6.37.Revenue for the quarter ended March 31 was $5.03 billion, compared with $4.73 billion a year earlier. Analysts polled by FactSet expected $4.97 billion.The company said it's reaffirming its 2026 guidance of mid-single-digit or greater organic revenue growth and "strong" adjusted EPS growth.Shares of Aon were up 3.5% in London.GSK's Linerixibat, to be marketed as Lynavoy, has been approved by the UK's Medicines and Healthcare products Regulatory Agency for the treatment of itching in adults with primary biliary cholangitis, the agency said Friday.The oral therapy aims to reduce bile acid buildup linked to the rare liver disease, which can cause persistent itching, the agency said.Shares of GSK were declining 1.5% in London.AstraZeneca said Thursday that the US Food and Drug Administration's Oncologic Drugs Advisory Committee has recognized a favorable benefit risk profile for Truqap in combination with abiraterone and androgen deprivation therapy for the treatment of patients with prostate cancer.The specific indication is for PTEN-deficient metastatic hormone-sensitive prostate cancer, the company said. The committee voted 7 to 1, with one member abstaining, AstraZeneca said.Shares of the British pharmaceutical company were falling close to 3% in London.Novo Nordisk said Friday it has rebranded its oral semaglutide medication for type 2 diabetes, formerly known as Rybelsus, as Ozempic.Starting Monday, Ozempic 1.5 mg, 4 mg and 9 mg tablets will be available for adults with type 2 diabetes in the US, the company said. Rybelsus was first approved by the FDA in 2019 and offered 3 mg, 7 mg and 14 mg tablets, the company said."The new Ozempic pill works similarly to semaglutide tablets 3 mg, 7 mg, and 14 mg and has the same efficacy and safety profile as the original formulation offered in a smaller pill," Novo Nordisk said.Shares of the Danish pharmaceutical company were up 1.4% in Copenhagen.NatWest reported Q1 earnings Friday of 0.179 British pound ($0.24) per basic share, up from 0.155 pound a year earlier. Analysts polled by FactSet expected 0.169 pound.Total income for the quarter ended March 31, expressed as the sum of net interest income and total noninterest income, was 4.36 billion pounds, up from 3.98 billion pounds a year earlier. Analysts surveyed by FactSet expected 4.30 billion pounds.For 2026, the company now expects income excluding notable items to be at the top end of its previous guidance range of 17.2 billion pounds to 17.6 billion pounds.Shares of the British bank were losing 3.2% in London.